XORTX Welcomes New Member to the Board of Directors and

CALGARY, Alberta, June 06, 2022 (GLOBE NEWSWIRE) -- XORTX Therapeutics Inc. ("XORTX" or the “Company”) (NASDAQ: XRTX | TSXV: XRTX | Frankfurt: ANU), a...

Related Keywords

Geneva ,Genè ,Switzerland ,Boston ,Massachusetts ,United States ,Canada ,Toronto ,Ontario ,Canadian ,Paul Van Damme ,Raymond Pratt ,Ian Klassen ,Nick Rigopulos ,Allen Davidoff ,Anthony Giovinazzo ,Anthonyj Giovinazzo ,Jaqueline Le Saux ,Bill Farley ,Sunovion Pharmaceuticals Dainippon Sumitomo ,Titan Medical Inc ,Osgoode Hall Law School ,Strategy In Pharmaceuticals ,Nasdaq ,Directors College ,Therapeutics Inc ,York University ,Venture Exchange ,Anthony ,Mcmaster University ,Drug Administration ,Audit Committee Certified ,Exchange Commission ,Harvard Business School ,Canadian Life Sciences ,Masters Of Business Administration ,Kalgene Inc ,Life Sciences ,Health Canada ,Special Protocol Assessment ,Central Nervous System ,Chief Executive Officer ,Cynapsus Therapeutics ,Sunovion Pharmaceuticals ,Dainippon Sumitomo Pharmaceuticals ,Executive Chair ,Toxic Oligomers ,Enos System ,Finance Monthly Game Changers ,Bloom Burton Award ,Chartered Director ,Business Administration ,Graduate Certificate Studies ,Canadian Law ,Autosomal Dominant Polycystic Kidney Disease ,Annual Information Form ,Management Discussion ,Tsx Venture Exchange Xrtx ,Ortx Therapeutics Inc ,